Literature DB >> 1996992

Interleukin-4 is a potent mitogen for capillary endothelium.

M Toi1, A L Harris, R Bicknell.   

Abstract

Interleukin-4 (IL-4) is a mitogen for both microvascular (human adrenal capillary, HACE) and large vessel (human umbilical vein, HUVEC) endothelial cells. Comparison of growth promotion by IL-4 to that by the potent endothelial mitogen fibroblast growth factor (FGF) showed the activity of IL-4 on HACE cells to be strong (50% of that with FGF) but on HUVEC's weak (12% of that with FGF). Growth stimulation was characterised by both 3H-thymidine incorporation and by cell number, and was maximal at 1 nM IL-4. The presence of IL-4 receptors on HACE cells and HUVEC's was confirmed by specific binding of radioiodinated IL-4. Scatchard analysis confirmed a single high affinity binding receptor on both HACE cells (Kd = 80 pM, 358 receptors/cell) and HUVEC's (Kd = 88 pM, 2,580 receptors/cell). Potent activity on capillary as opposed to large vessel endothelium places IL-4 in a unique position amongst endothelial mitogens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1996992     DOI: 10.1016/0006-291x(91)91561-p

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  Interaction of Bartonella henselae with endothelial cells promotes monocyte/macrophage chemoattractant protein 1 gene expression and protein production and triggers monocyte migration.

Authors:  Amy M McCord; Andrew W O Burgess; Melissa J Whaley; Burt E Anderson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Gene expression and angiotropism in primary CNS lymphoma.

Authors:  James L Rubenstein; Jane Fridlyand; Arthur Shen; Ken Aldape; David Ginzinger; Tracy Batchelor; Patrick Treseler; Mitchel Berger; Michael McDermott; Michael Prados; Jon Karch; Craig Okada; William Hyun; Seema Parikh; Chris Haqq; Marc Shuman
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

Review 3.  Inhibition of fibroblast growth factors.

Authors:  A Wellstein; F Czubayko
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

4.  Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4.

Authors:  R Brinckmann; M S Topp; I Zalán; D Heydeck; P Ludwig; H Kühn; W E Berdel; J R Habenicht
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

5.  Evaluation of laser doppler flowmetry for the study of benign and malignant gastric blood flow in vivo.

Authors:  M K Schilling; C Redaelli; H Friess; B Blum; C Signer; C A Maurer; M W Büchler
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

6.  Interleukin-4 rapidly inhibits calcium transients in response to carbachol in bovine airway smooth muscle cells.

Authors:  J M Madison; M F Ethier
Journal:  Am J Respir Cell Mol Biol       Date:  2001-08       Impact factor: 6.914

7.  Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.

Authors:  B Schnyder; H Lahm; G Woerly; N Odartchenko; B Ryffel; B D Car
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

8.  Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).

Authors:  B König; A Fischer; W König
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

9.  Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation.

Authors:  M L Estes; K Iwasaki; B S Jacobs; B P Barna
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

10.  Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells.

Authors:  N I Obiri; J P Siegel; F Varricchio; R K Puri
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.